United States Gene Therapy Market Report 2017

January 2017 | 102 pages | ID: U3EF274F2B1EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Gene Therapy

Revenue, means the sales value of Gene Therapy

This report studies sales (consumption) of Gene Therapy in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Bluebird Bio
• Sangamo
• Spark Therapeutics
• Dimension Therapeutics
• Avalanche Bio
• Celladon
• Vical Inc.
• Advantagene

Market Segment by States, covering

• California
• Texas
• New York
• Florida
• Illinois

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• In Vivo
• Ex Viv

Split by applications, this report focuses on sales, market share and growth rate of Gene Therapy in each application, can be divided into

• Mechanobiology Universities
• Research Institutions
• Other

Contents

United States Gene Therapy Market Report 2017

1 GENE THERAPY OVERVIEW

1.1 Product Overview and Scope of Gene Therapy
1.2 Classification of Gene Therapy
  1.2.1 In Vivo
  1.2.2 Ex Viv
1.3 Application of Gene Therapy
  1.3.1 Mechanobiology Universities
  1.3.2 Research Institutions
  1.3.3 Other
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Gene Therapy (2011-2021)
  1.4.1 United States Gene Therapy Sales and Growth Rate (2011-2021)
  1.4.2 United States Gene Therapy Revenue and Growth Rate (2011-2021)

2 UNITED STATES GENE THERAPY COMPETITION BY MANUFACTURERS

2.1 United States Gene Therapy Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Gene Therapy Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Gene Therapy Average Price by Manufactures (2015 and 2016)
2.4 Gene Therapy Market Competitive Situation and Trends
  2.4.1 Gene Therapy Market Concentration Rate
  2.4.2 Gene Therapy Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES GENE THERAPY SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2011-2016)

3.1 United States Gene Therapy Sales and Market Share by States (2011-2016)
3.2 United States Gene Therapy Revenue and Market Share by States (2011-2016)
3.3 United States Gene Therapy Price by States (2011-2016)

4 UNITED STATES GENE THERAPY SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

4.1 United States Gene Therapy Sales and Market Share by Type (2011-2016)
4.2 United States Gene Therapy Revenue and Market Share by Type (2011-2016)
4.3 United States Gene Therapy Price by Type (2011-2016)
4.4 United States Gene Therapy Sales Growth Rate by Type (2011-2016)

5 UNITED STATES GENE THERAPY SALES (VOLUME) BY APPLICATION (2011-2016)

5.1 United States Gene Therapy Sales and Market Share by Application (2011-2016)
5.2 United States Gene Therapy Sales Growth Rate by Application (2011-2016)
5.3 Market Drivers and Opportunities

6 UNITED STATES GENE THERAPY MANUFACTURERS PROFILES/ANALYSIS

6.1 Bluebird Bio
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Gene Therapy Product Type, Application and Specification
    6.1.2.1 In Vivo
    6.1.2.2 Ex Viv
  6.1.3 Bluebird Bio Gene Therapy Sales, Revenue, Price and Gross Margin (2011-2016)
  6.1.4 Main Business/Business Overview
6.2 Sangamo
  6.2.2 Gene Therapy Product Type, Application and Specification
    6.2.2.1 In Vivo
    6.2.2.2 Ex Viv
  6.2.3 Sangamo Gene Therapy Sales, Revenue, Price and Gross Margin (2011-2016)
  6.2.4 Main Business/Business Overview
6.3 Spark Therapeutics
  6.3.2 Gene Therapy Product Type, Application and Specification
    6.3.2.1 In Vivo
    6.3.2.2 Ex Viv
  6.3.3 Spark Therapeutics Gene Therapy Sales, Revenue, Price and Gross Margin (2011-2016)
  6.3.4 Main Business/Business Overview
6.4 Dimension Therapeutics
  6.4.2 Gene Therapy Product Type, Application and Specification
    6.4.2.1 In Vivo
    6.4.2.2 Ex Viv
  6.4.3 Dimension Therapeutics Gene Therapy Sales, Revenue, Price and Gross Margin (2011-2016)
  6.4.4 Main Business/Business Overview
6.5 Avalanche Bio
  6.5.2 Gene Therapy Product Type, Application and Specification
    6.5.2.1 In Vivo
    6.5.2.2 Ex Viv
  6.5.3 Avalanche Bio Gene Therapy Sales, Revenue, Price and Gross Margin (2011-2016)
  6.5.4 Main Business/Business Overview
6.6 Celladon
  6.6.2 Gene Therapy Product Type, Application and Specification
    6.6.2.1 In Vivo
    6.6.2.2 Ex Viv
  6.6.3 Celladon Gene Therapy Sales, Revenue, Price and Gross Margin (2011-2016)
  6.6.4 Main Business/Business Overview
6.7 Vical Inc.
  6.7.2 Gene Therapy Product Type, Application and Specification
    6.7.2.1 In Vivo
    6.7.2.2 Ex Viv
  6.7.3 Vical Inc. Gene Therapy Sales, Revenue, Price and Gross Margin (2011-2016)
  6.7.4 Main Business/Business Overview
6.8 Advantagene
  6.8.2 Gene Therapy Product Type, Application and Specification
    6.8.2.1 In Vivo
    6.8.2.2 Ex Viv
  6.8.3 Advantagene Gene Therapy Sales, Revenue, Price and Gross Margin (2011-2016)
  6.8.4 Main Business/Business Overview

7 GENE THERAPY MANUFACTURING COST ANALYSIS

7.1 Gene Therapy Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Gene Therapy

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Gene Therapy Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Gene Therapy Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES GENE THERAPY MARKET FORECAST (2016-2021)

11.1 United States Gene Therapy Sales, Revenue Forecast (2016-2021)
11.2 United States Gene Therapy Sales Forecast by Type (2016-2021)
11.3 United States Gene Therapy Sales Forecast by Application (2016-2021)
11.4 Gene Therapy Price Forecast (2016-2021)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Methodology
Analyst Introduction
Data Source


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Gene Therapy
Table Classification of Gene Therapy
Figure United States Sales Market Share of Gene Therapy by Type in 2015
Figure In Vivo Picture
Figure Ex Viv Picture
Table Application of Gene Therapy
Figure United States Sales Market Share of Gene Therapy by Application in 2015
Figure Mechanobiology Universities Examples
Figure Research Institutions Examples
Figure Other Examples
Figure United States Gene Therapy Sales and Growth Rate (2011-2021)
Figure United States Gene Therapy Revenue and Growth Rate (2011-2021)
Table United States Gene Therapy Sales of Key Manufacturers (2015 and 2016)
Table United States Gene Therapy Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Gene Therapy Sales Share by Manufacturers
Figure 2016 Gene Therapy Sales Share by Manufacturers
Table United States Gene Therapy Revenue by Manufacturers (2015 and 2016)
Table United States Gene Therapy Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Gene Therapy Revenue Share by Manufacturers
Table 2016 United States Gene Therapy Revenue Share by Manufacturers
Table United States Market Gene Therapy Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Gene Therapy Average Price of Key Manufacturers in 2015
Figure Gene Therapy Market Share of Top 3 Manufacturers
Figure Gene Therapy Market Share of Top 5 Manufacturers
Table United States Gene Therapy Sales by States (2011-2016)
Table United States Gene Therapy Sales Share by States (2011-2016)
Figure United States Gene Therapy Sales Market Share by States in 2015
Table United States Gene Therapy Revenue and Market Share by States (2011-2016)
Table United States Gene Therapy Revenue Share by States (2011-2016)
Figure Revenue Market Share of Gene Therapy by States (2011-2016)
Table United States Gene Therapy Price by States (2011-2016)
Table United States Gene Therapy Sales by Type (2011-2016)
Table United States Gene Therapy Sales Share by Type (2011-2016)
Figure United States Gene Therapy Sales Market Share by Type in 2015
Table United States Gene Therapy Revenue and Market Share by Type (2011-2016)
Table United States Gene Therapy Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Gene Therapy by Type (2011-2016)
Table United States Gene Therapy Price by Type (2011-2016)
Figure United States Gene Therapy Sales Growth Rate by Type (2011-2016)
Table United States Gene Therapy Sales by Application (2011-2016)
Table United States Gene Therapy Sales Market Share by Application (2011-2016)
Figure United States Gene Therapy Sales Market Share by Application in 2015
Table United States Gene Therapy Sales Growth Rate by Application (2011-2016)
Figure United States Gene Therapy Sales Growth Rate by Application (2011-2016)
Table Bluebird Bio Basic Information List
Table Bluebird Bio Gene Therapy Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bluebird Bio Gene Therapy Sales Market Share (2011-2016)
Table Sangamo Basic Information List
Table Sangamo Gene Therapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sangamo Gene Therapy Sales Market Share (2011-2016)
Table Spark Therapeutics Basic Information List
Table Spark Therapeutics Gene Therapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table Spark Therapeutics Gene Therapy Sales Market Share (2011-2016)
Table Dimension Therapeutics Basic Information List
Table Dimension Therapeutics Gene Therapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table Dimension Therapeutics Gene Therapy Sales Market Share (2011-2016)
Table Avalanche Bio Basic Information List
Table Avalanche Bio Gene Therapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table Avalanche Bio Gene Therapy Sales Market Share (2011-2016)
Table Celladon Basic Information List
Table Celladon Gene Therapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table Celladon Gene Therapy Sales Market Share (2011-2016)
Table Vical Inc. Basic Information List
Table Vical Inc. Gene Therapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table Vical Inc. Gene Therapy Sales Market Share (2011-2016)
Table Advantagene Basic Information List
Table Advantagene Gene Therapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table Advantagene Gene Therapy Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Gene Therapy
Figure Manufacturing Process Analysis of Gene Therapy
Figure Gene Therapy Industrial Chain Analysis
Table Raw Materials Sources of Gene Therapy Major Manufacturers in 2015
Table Major Buyers of Gene Therapy
Table Distributors/Traders List
Figure United States Gene Therapy Production and Growth Rate Forecast (2016-2021)
Figure United States Gene Therapy Revenue and Growth Rate Forecast (2016-2021)
Table United States Gene Therapy Production Forecast by Type (2016-2021)
Table United States Gene Therapy Consumption Forecast by Application (2016-2021)
Table United States Gene Therapy Sales Forecast by States (2016-2021)
Table United States Gene Therapy Sales Share Forecast by States (2016-2021)